Clinical Trials Browser

Phase 3 × Interventional × Escitalopram × Clear all

Breast Neoplasms, Depressive Disorder, Major

NCT04763135 2023-06-08

MIR-P

Phase 3 Terminated

1 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT02246244 2016-06-10

TADDOR

Phase 3 Completed

38 enrolled

ENT Cancer

NCT00387348 2012-12-03

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Phase 3 Terminated

24 enrolled 11 charts

GastrointestinalThoracic

Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Depression, Esophageal Neoplasms, Fatigue, Gallbladder Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00935675 2009-09-02

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment

Phase 3 Unknown

100 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma

Clinical Trials

IPT

MIR-P

TADDOR

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment